1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Editorial
You have full text access to this OnlineOpen article
Molecular ablation of transforming growth factor β signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis
Article first published online: 30 JUL 2008
DOI: 10.1002/art.23634
Copyright © 2008 by the American College of Rheumatology
Additional Information
How to Cite
Rosenbloom, J. and Jiménez, S. A. (2008), Molecular ablation of transforming growth factor β signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis. Arthritis & Rheumatism, 58: 2219–2224. doi: 10.1002/art.23634
Publication History
- Issue published online: 30 JUL 2008
- Article first published online: 30 JUL 2008
- Manuscript Accepted: 18 APR 2008
- Manuscript Received: 26 MAR 2008
Funded by
- NIH. Grant Number: R01-AR-019616
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Treatment of interstitial lung diseases associated with connective tissue diseases, Expert Review of Clinical Pharmacology, 2012, 5, 2, 219
- 2
- 3, , Tyrosine kinase inhibitor therapy for systemic sclerosis: Quo Vadis?, Arthritis & Rheumatism, 2011, 63, 11Direct Link:
- 4, , , , , Scleroderma Lung Disease, Clinical Reviews in Allergy & Immunology, 2010, 40, 2, 104
- 5
- 6, , , , , , , , A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate, Oncogene, 2009, 28, 10, 1285
- 7, , , Function and dysfunction of dendritic cells in autoimmune rheumatic diseases, Human Immunology, 2009, 70, 5, 360
- 8, , , , , , , , Polymorphism of the TGFB1 gene is not associated with bronchial allergic asthma in a Polish population, Human Immunology, 2009, 70, 2, 134
- 9, , Transforming growth factor β as a therapeutic target in systemic sclerosis, Nature Reviews Rheumatology, 2009, 5, 4, 200
- 10Angiotensin II Blockade in Marfan's Syndrome, New England Journal of Medicine, 2008, 359, 16, 1732
- 11, , , Caveolin-1, transforming growth factor-β receptor internalization, and the pathogenesis of systemic sclerosis, Current Opinion in Rheumatology, 2008, 20, 6, 713
- 12, , Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease, Expert Opinion on Pharmacotherapy, 2008, 9, 18, 3221